炎症性肠病中的Toll样受体——踏入未知领域
Toll-like receptors in inflammatory bowel disease-stepping into uncharted territory.
作者信息
Levin Avi, Shibolet Oren
机构信息
Liver Unit, Division of Medicine, POB 12000, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel.
出版信息
World J Gastroenterol. 2008 Sep 7;14(33):5149-53. doi: 10.3748/wjg.14.5149.
Abstract
Ulcerative colitis and Crohn's disease are chronic relapsing-remitting inflammatory processes of the intestinal tract. The etiology of these diseases is currently unknown. However, inflammation is hypothesized to result from inappropriate activation of mucosal immunity by luminal antigens in genetically susceptible individuals. Toll-like receptors (TLRs) are a family of transmembrane proteins that act as microbial pattern recognition receptors. They are crucial initiators of innate immune responses. The role of TLRs in the pathogenesis of inflammatory bowel disease (IBD) has not been fully elucidated. In this review, we aim to analyze the available data connecting individual TLRs to intestinal inflammation and IBD.
摘要
溃疡性结肠炎和克罗恩病是肠道的慢性复发性炎症过程。目前这些疾病的病因尚不清楚。然而，据推测，在基因易感个体中，炎症是由管腔抗原对黏膜免疫的不适当激活所致。Toll样受体（TLRs）是一类作为微生物模式识别受体的跨膜蛋白。它们是先天性免疫反应的关键启动因子。TLRs在炎症性肠病（IBD）发病机制中的作用尚未完全阐明。在本综述中，我们旨在分析将个体TLRs与肠道炎症和IBD联系起来的现有数据。
相似文献
1
Toll-like receptors in inflammatory bowel disease-stepping into uncharted territory.炎症性肠病中的Toll样受体——踏入未知领域
World J Gastroenterol. 2008 Sep 7;14(33):5149-53. doi: 10.3748/wjg.14.5149.
2
3
Commentary: the role of the IL-18 system and other members of the IL-1R/TLR superfamily in innate mucosal immunity and the pathogenesis of inflammatory bowel disease: friend or foe?述评：白细胞介素-18系统及白细胞介素-1受体/Toll样受体超家族其他成员在先天性黏膜免疫及炎症性肠病发病机制中的作用：是友还是敌？
Eur J Immunol. 2004 Sep;34(9):2347-55. doi: 10.1002/eji.200425351.
4
Role of toll-like receptors in inflammatory bowel disease.Toll 样受体在炎症性肠病中的作用。
Pharmacol Res. 2018 Mar;129:204-215. doi: 10.1016/j.phrs.2017.11.017. Epub 2017 Nov 16.
5
Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?溃疡性结肠炎和克罗恩病中Toll样受体关键调节因子的差异表达：Tollip和过氧化物酶体增殖物激活受体γ的作用？
Clin Exp Immunol. 2016 Mar;183(3):358-68. doi: 10.1111/cei.12732. Epub 2015 Nov 26.
6
Delineating the Role of Toll-Like Receptors in Inflammatory Bowel Disease.阐明 Toll 样受体在炎症性肠病中的作用。
Methods Mol Biol. 2023;2700:221-228. doi: 10.1007/978-1-0716-3366-3_13.
7
Innate immunity in inflammatory bowel disease.炎症性肠病中的固有免疫
World J Gastroenterol. 2007 Nov 14;13(42):5577-80. doi: 10.3748/wjg.v13.i42.5577.
8
Toll-Like Receptors as Drug Targets in the Intestinal Epithelium.Toll 样受体作为肠道上皮的药物靶点。
Handb Exp Pharmacol. 2022;276:291-314. doi: 10.1007/164_2021_563.
9
The role of innate immunity receptors in the pathogenesis of inflammatory bowel disease.天然免疫受体在炎症性肠病发病机制中的作用。
Mediators Inflamm. 2015;2015:936193. doi: 10.1155/2015/936193. Epub 2015 Mar 4.
10
Toll-like Receptors and Inflammatory Bowel Disease.Toll 样受体与炎症性肠病。
Front Immunol. 2018 Jan 30;9:72. doi: 10.3389/fimmu.2018.00072. eCollection 2018.
引用本文的文献
1
Mechanisms of the effects of turpiniae folium extract on growth performance, immunity, antioxidant activity and intestinal barrier function in LPS-challenged broilers.山香圆叶提取物对脂多糖攻击的肉鸡生长性能、免疫力、抗氧化活性及肠道屏障功能的影响机制
Poult Sci. 2025 Apr;104(4):104903. doi: 10.1016/j.psj.2025.104903. Epub 2025 Feb 17.
2
Toll-Like Receptor 7 a Novel Non-Invasive Inflammatory Genetic Sensor for Ulcerative Colitis Remission Monitoring.Toll样受体7：一种用于溃疡性结肠炎缓解监测的新型非侵入性炎症基因传感器
Adv Biomed Res. 2023 Feb 25;12:54. doi: 10.4103/abr.abr_24_22. eCollection 2023.
3
Protective Role of the Toll-Like Receptor 5 Agonist KMRC011 against Murine Colitis Induced by and Dextran Sulfate Sodium.TLR5 激动剂 KMRC011 对葡聚糖硫酸钠和葡聚糖硫酸钠诱导的小鼠结肠炎的保护作用。
J Microbiol Biotechnol. 2023 Jan 28;33(1):35-42. doi: 10.4014/jmb.2209.09048. Epub 2022 Nov 15.
4
Extracellular vesicles produced by the human commensal gut bacterium Bacteroides thetaiotaomicron affect host immune pathways in a cell-type specific manner that are altered in inflammatory bowel disease.人共生肠道细菌拟杆菌 Bacteroides thetaiotaomicron 产生的细胞外囊泡以细胞类型特异性的方式影响宿主免疫途径，而在炎症性肠病中这些途径发生改变。
J Extracell Vesicles. 2022 Jan;11(1):e12189. doi: 10.1002/jev2.12189.
5
Oral Nanoparticles of SNX10-shRNA Plasmids Ameliorate Mouse Colitis.口服 SNX10-shRNA 质粒纳米颗粒改善小鼠结肠炎。
Int J Nanomedicine. 2021 Jan 13;16:345-357. doi: 10.2147/IJN.S286392. eCollection 2021.
6
Effect of chemical modulation of toll-like receptor 4 in an animal model of ulcerative colitis.溃疡性结肠炎动物模型中Toll样受体4化学调节的作用
Eur J Clin Pharmacol. 2020 Mar;76(3):409-418. doi: 10.1007/s00228-019-02799-7. Epub 2020 Jan 25.
7
IgG4+ plasma cell infiltration is correlated with the development of inflammatory bowel disease and can be regulated by TLR-4.IgG4+浆细胞浸润与炎症性肠病的发展相关，且可由Toll样受体4（TLR-4）调控。
Int J Clin Exp Pathol. 2018 Sep 1;11(9):4537-4544. eCollection 2018.
8
Succinylated chitosan derivative has local protective effects on intestinal inflammation.琥珀酰化壳聚糖衍生物对肠道炎症具有局部保护作用。
ACS Biomater Sci Eng. 2017;3(8):1853-1860. doi: 10.1021/acsbiomaterials.7b00262. Epub 2017 Jun 5.
9
Toll-Like Receptors: Regulators of the Immune Response in the Human Gut.Toll 样受体：人类肠道中免疫反应的调节剂。
Nutrients. 2018 Feb 13;10(2):203. doi: 10.3390/nu10020203.
10
Myeloid differentiation primary response gene (MyD) 88 signalling is not essential for intestinal fibrosis development.髓系分化初级反应基因 88 信号传导对于肠道纤维化的发展并非必需。
Sci Rep. 2017 Dec 15;7(1):17678. doi: 10.1038/s41598-017-17755-7.
本文引用的文献
1
Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis.胞壁酰二肽激活核苷酸结合寡聚化结构域2可保护小鼠免受实验性结肠炎的侵害。
J Clin Invest. 2008 Feb;118(2):545-59. doi: 10.1172/JCI33145.
2
The c.1-260C>T promoter variant of CD14 but not the c.896A>G (p.D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel disease.CD14基因的c.1-260C>T启动子变异而非Toll样受体4（TLR4）基因的c.896A>G（p.D299G）变异与炎症性肠病相关。
Digestion. 2007;76(3-4):196-202. doi: 10.1159/000112646. Epub 2007 Dec 21.
3
Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis.炎症性肠病患者活检样本中Toll样受体2（TLR2）、TLR4和CD14的表达：溃疡性结肠炎患者回肠末端TLR2表达上调。
J Histochem Cytochem. 2008 Mar;56(3):267-74. doi: 10.1369/jhc.7A7303.2007. Epub 2007 Nov 26.
4
Deletion of TLR5 results in spontaneous colitis in mice.Toll样受体5的缺失会导致小鼠出现自发性结肠炎。
J Clin Invest. 2007 Dec;117(12):3909-21. doi: 10.1172/JCI33084.
5
Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease.炎症性肠病患儿结肠黏膜中Toll样受体（TLR）2和TLR4表达增加。
Clin Exp Immunol. 2008 Jan;151(1):34-41. doi: 10.1111/j.1365-2249.2007.03531.x. Epub 2007 Nov 7.
6
Has toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association.Toll样受体4是否被过早地排除在炎症性肠病基因之外？联合荟萃分析的关联研究显示了其关联的有力证据。
Am J Gastroenterol. 2007 Nov;102(11):2504-12. doi: 10.1111/j.1572-0241.2007.01463.x. Epub 2007 Sep 10.
7
Unravelling the pathogenesis of inflammatory bowel disease.揭示炎症性肠病的发病机制。
Nature. 2007 Jul 26;448(7152):427-34. doi: 10.1038/nature06005.
8
NKG2D recognition mediates Toll-like receptor 3 signaling-induced breakdown of epithelial homeostasis in the small intestines of mice.NKG2D识别介导Toll样受体3信号诱导的小鼠小肠上皮稳态破坏。
Proc Natl Acad Sci U S A. 2007 May 1;104(18):7512-5. doi: 10.1073/pnas.0700822104. Epub 2007 Apr 26.
9
Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function.Toll样受体2通过调节上皮屏障功能来控制黏膜炎症。
Gastroenterology. 2007 Apr;132(4):1359-74. doi: 10.1053/j.gastro.2007.02.056. Epub 2007 Feb 25.
10
Activation of toll-like receptor 3 protects against DSS-induced acute colitis.Toll样受体3的激活可预防右旋糖酐硫酸钠诱导的急性结肠炎。
Inflamm Bowel Dis. 2007 Jul;13(7):856-64. doi: 10.1002/ibd.20142.
Zotero 插件